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Abstract
Background: The overall objective of the Ansan Geriatric Study (AGE study) was to describe the
prevalence, incidence, and related risk factors for geriatric diseases in elderly Koreans.
Methods/Design: The AGE study was designed as a population-based prospective cohort study
on health, aging, and common geriatric diseases of elderly Koreans aged 60 to 84 years. The
inception cohort was recruited in May 2002. The first-wave and second-wave studies were
performed using uniform and structured procedures. At the screening study, 2,767 participants
were enrolled. Participants (1391 in the first wave study and 841 in the second wave study) were
recruited and completed the evaluation. The prevalence of geriatric disease and related factors in
elderly Koreans were estimated.
Discussion: Here, we report the design and sampling participants, measurement tools, and
characteristics of the AGE study. This cohort study will allow a detailed study of the longitudinal
comprehensive data on health information of elderly Koreans, thereby contributing to policy
formulation and planning of health, welfare management, and other social services in Korea.
Background
More than one-quarter of the world's population will be
over the age of 60 by the year 2010 [1]. As in most other
countries, the proportion of elderly people in Korea is
increasing every year due to decreased birth rates and
increased longevity. The proportion of those 65 years and
older in Korea was approximately 8.3% in 2003 and is
expected to rise to 15% in 2019 [2]. As Korea will have the
highest proportion of elderly people in the world by 2050,
public health concerns about geriatric diseases in Korea
have taken on greater importance. There are increasing
demands for national policies and programs to deal with
problems affecting the elderly. Thus, there is a need for
research focusing on age-related conditions that contrib-
ute significantly to chronic illness and disability in elderly
Koreans.
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studies such as the Baltimore Longitudinal Study on Aging
in the USA [3], the Framingham study in the USA [4], the
Rotterdam elderly study in the Netherlands [5], and the
Canadian Study on Health and Aging in Canada [6], there
have been a few longitudinal cohort studies with elderly
Asians. The Honolulu Asia Aging Study [7] investigated
men only, whereas longitudinal cohort studies on elderly
Koreans including the Hallym Aging Study (HAS) [8], the
Gwangju dementia and mild cognitive impairment study
(GDEMCIS) [9], and the Korean Longitudinal Study on
Health and Aging (KLoSHA) [10] had some methodolog-
ical problems; a precise neuropsychological test was not
performed, the subjects were recruited without popula-
tion-based random sampling, or there was only cross-sec-
tional evaluation.
The Ansan Geriatric study (AGE study) was designed to
establish a prospective population-based cohort of sub-
jects to study prevalence, incidence, and related risk fac-
tors for geriatric diseases and to obtain comprehensive
information on public health and functional status in eld-
erly Koreans. Here, we describe the design, sampling, par-
ticipants, baseline measures, and sample characteristics of
this study.
Methods
Study design and sampling population
As part of a baseline investigation to construct an elderly
cohort in Korea, we sampled the elderly population living
in Ansan-city, located 25 miles (40 km) southwest of
Seoul and now considered a part of the metropolitan area
of Seoul. According to the 2002 census, Ansan is an urban
community with an elderly population of 36,735, aged 60
to 84 years. We assumed that the prevalence of major ger-
iatric disease such as dementia would be 10–13% in the
elderly Korean [11,12]. We wish to determine this preva-
lence to within about 1%, that is have a confidence inter-
val of width 2% with 95% confidence, the number of
subjects required is approximately 3000 [13].
The sampling protocol and design of the AGE study for a
baseline investigation (screening study) have been well
described previously [14-16]. Briefly, to enroll partici-
pants, we used a list of telephone numbers obtained from
local telephone companies because the community has a
high percentage of telephone subscribership. We con-
ducted a two-stage cluster sampling based on information
from the governing district, called "dong," and from the
telephone directory, obtaining information on age and
sex distribution from the 2002 census. To acquire a prob-
ability sample proportional to the age- and gender-spe-
cific population structure of the target population, a
random sampling comprised 15,392 persons (41.9%)
aged 60 to 84 years was selected. A letter inviting partici-
pation in this study was initially sent to all 15,392 individ-
uals and they were additionally contacted at least three
times either by telephone or were visited at home to con-
firm their eligibility. After the exclusion of individuals
who were determined ineligible for interview, a total of
4,404 eligible individuals (12% of the target population
or 28.6% of the stratified random sample) underwent
baseline evaluation. After excluding persons who pro-
vided incomplete data or were ineligible for a probability
sample proportional to the age- and gender-specific struc-
ture of the target population, the final sample comprised
2,767 elderly Koreans representative of the target popula-
tion.
From the baseline investigation database, we constructed
a first-wave study with a probability sample proportional
to the age- and gender-specific population as described
previously [17,18]. A total of 1,391 subjects (595 men and
796 women) were randomly recruited between Septem-
ber 2004 and March 2006. Recruits participated in a com-
prehensive health examination and on-site interviews at
the Geriatric Health Clinic Research Institute, Korea Uni-
versity Ansan Hospital. The first-wave study participants
were evaluated with clinical and neuropsychological
examinations and were subjected to genotyping for the
APOE ε4 polymorphism. In this elderly population, some
participants did not complete follow-up at all intervals
because of refusal, relocation, or death.
The follow-up assessment occurred from April 2006 to
January 2008 (second-wave study; 25.61 ± 5.08 months),
with uniform, structured follow-up evaluations by exam-
iners that were blinded to the previously collected data. A
total of 841 subjects were randomly recruited from the
first-wave study. Variations in follow-up time, which
ranged from 11 to 45 months, resulted from variations in
response time to one or several invitations. The second-
wave data collection was essentially the same as the first-
wave study. Future follow-up assessments will be per-
formed at regular intervals. The participants of the AGE
study will be re-examined using the same procedures used
in the previous assessments.
Procedures were in accordance with institutional guide-
lines and were approved by an institutional review com-
mittee. Informed written consent for participation was
obtained from each individual and the study protocol was
approved by the institutional review board of the AGE
study.
Neuropsychological examination
During the first-wave study, a comprehensive and vali-
dated battery of neuropsychological tests was performed
by trained neuropsychologists. The Word Fluency Test,
the 15-item Korean version of the Boston Naming Test,Page 2 of 7
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(MMSE-KC), the Word List Memory test, the Construc-
tional Praxis test, the Word Delayed Recall test, the Word
Recognition test, the Construction Recall test, and the
Korean version of the Consortium to Establish a Registry
for Alzheimer's Disease (CERAD) neuropsychological
assessment battery of tests (CERAD-K) [19] were adminis-
tered. Additionally, we also administered part of the series
of neuropsychological tests in the Seoul Neuropsycholog-
ical Screening Battery (SNSB) [20] to assess other specific
cognitive domains: The Digit Span Test and Calculation
for attention, and the Contrasting Program, Go-No-Go
Test, Fist-Edge-Palm, Alternating Hand Movement Test,
and Alternating Square and Triangle Test for frontal exec-
utive functions. The total score for the CERAD neuropsy-
chological battery was used as an index of the overall level
of cognitive functioning of the participants [21]. The Clin-
ical Dementia Rating Scale (CDR) was also administered
[22]. The CDR was based on a structured caregiver inter-
view. Scores were obtained in six different functional
domains (memory, orientation, judgment and problem
solving, community affairs, home and hobbies, and per-
sonal care). A variety of scores can be calculated but for
the purposes of this study we used the "sum of boxes"
score which was the arithmetic sum of the six subscores
[23]. Neither instrument was used in any algorithmic way
to determine clinical diagnosis and instrument scores
could diverge from clinical diagnosis.
Dementia was defined according to the diagnostic fea-
tures of dementia given in the Diagnostic and Statistical
Manual of Mental Disorders, fourth edition (DSM-IV)
[24]. The sub-diagnosis of possible or probable Alzhe-
imer' disease (AD) was based on the National Institute of
Neurological and Communicative Disease and Stroke-
Alzheimer's Disease and Related Disorder Association cri-
teria (NINCDS-ADRDA) [25]. Vascular dementia (VD)
was diagnosed according to the National Institute of Neu-
rological Disorders and Stroke-Association Internationale
pour la Recherche et l'Enseignement en Neurosciences
(NINDS-AIREN) criteria possible VD [26]. The Hachinski
ischemic score was determined to estimate the vascular
contribution to cognitive decline [27].
Mild Cognitive Impairment (MCI) was diagnosed on the
basis of the International Working Group on Mild Cogni-
tive Impairment [28] as follows. Objective cognitive
impairment was assessed using tasks in four specific cog-
nitive domains: Memory, language function, visuospatial
function, and frontal executive function. Briefly, memory
was assessed with the Word List Recall [19] and Construc-
tional Recall tests [19]. Language function was assessed
with the modified Korean version of the Boston Naming
Test [29]. Visuospatial function was assessed with the
Constructional Praxis test where four line drawings of fig-
ures with increasing complexity are presented to the sub-
jects for copying [30]. Frontal executive function was
assessed with the motor and fluency domains. The motor
domain was assessed by the Contrasting Program test, the
Go-No-Go test, the Fist-Edge-Palm test, the Alternating
Hand Movement test, the Alternating Square and Triangle
test, and the Luria loop test [31]. Motor impairment was
defined as the condition where three or more tests showed
abnormal results. The fluency domain was assessed by cat-
egory fluency of the Korean version of the Controlled Oral
Word Association Test [32]. Cognitive impairment was
defined as an average composite score 1.0 SD below the
age-, gender-, and education-specific mean of non-
demented persons on the respective tests to conform to
published criteria [33,34]. Furthermore, for the need for
supervision or external help in performing any basic and
instrumental activities of daily living (functional depend-
ency due to physical impairment was not considered) was
evaluated for all participants. Activities of daily living were
assessed by the Barthel ADL [35] and the Korean Instru-
mental ADL [36], and the absence of DSM-IV clinical cri-
teria for dementia was also assessed [24]. Although the
consensus criteria also include confirmation of subjective
memory complaints, this criterion was not included in the
AGE study because its use in elderly Koreans [37] and
population-based investigations has been questioned
[38,39]. The clinical diagnosis of MCI was classified
according to three subtypes: Single amnesic, multiple
amnesic, single non-amnesic and multiple non-amnesic
domains impaired, as described in a previous study [28].
Symptoms of depression were determined according to
the Korean version of the 30-item Geriatric Depression
Scale (GDS-K) [40] and the Korean version of the PHQ-9
[41]. The geriatric quality of life scale (GQOL) [42] and
the Mini International Neuropsychiatric Interview (MINI)
[43] were also administered to the participants. The final
diagnosis was based upon a consensus meeting, attended
by at least a neurologist, neuropsychologist, psychiatrist,
and specialized nurse, where all the available clinical data
and the results of the ancillary investigations were
reviewed.
Physical examination and interview
Each study participant received a comprehensive physical
examination and completed an interviewer-administered
questionnaire. Detailed data on sociodemographic factors
and personal characteristics were collected including age,
income, occupation, marital status, and education. Infor-
mation on individual and familial medical history includ-
ing dementia, depression, hypertension, diabetes,
dyslipidemia was collected, as was information relating to
other lifestyle factors including smoking status, alcohol
intake, and physical activity [14,18]. To ensure uniform-
ity, all interviewers underwent two days of training beforePage 3 of 7
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lected. McNemar's test was used to assess inter-surveyor
reliability; no significant differences were seen (P > 0.05)
[15].
Blood pressure
Blood pressure measurements were performed with a
mercury sphygmomanometer in a standardized cuff size
adjusted to the circumference of the arm. The arm was
placed with the cuff at the level of heart. Blood pressure
was recorded using the means of 2nd and 3rd measure-
ments taken after 5 minutes of rest in the supine position.
Systolic and diastolic blood pressures were defined
according to Korotkoff sounds I and V.
Anthropometric measurements
The anthropometric measurements of each participant
were taken after an overnight fast and while wearing light
clothing and no shoes. Height was determined using a
fixed wall-scale measuring device and was measured to
the nearest 0.1 cm. Weight was determined within 0.1 kg
for each subject using an electronic scale that was cali-
brated prior to each measurement. Body mass index
(BMI) was calculated as weight in kilograms divided by
the square of height in meters.
The waist-hip ratio (WHR) and waist circumference (WC)
were used to assess android and central obesity. WC was
measured over the umbilicus between the lower border of
the ribs and the iliac crest in a horizontal plane. Hip cir-
cumference was measured over the widest point of the
buttocks. Both the waist and hip circumference were
measured twice and recorded to the nearest 0.5 cm. If the
variation between these two measurements was greater
than 2 cm, then a third measurement was taken and the
mean was calculated by using the two closest recorded
measurements. WHR was obtained by dividing the WC by
the hip circumference.
The percent body fat (PBF) indicates the percentage of
body fat to body weight. Bioelectrical impedance analysis
was used to measure the PBF [44]. The PBF measurement
that is derived from a bioelectrical impedance analysis is
less accurate than measurements obtained by dual-energy
X-ray absorptiometry. However, this method of estimat-
ing body composition has become increasingly popular
because it is easy to use, non-invasive, relatively inexpen-
sive, provides an accurate method for the assessment of
body composition, and can be performed across a wide
range of subjects with regard to age and body shape [45].
PBF was obtained by using segmental bioelectrical imped-
ance with eight tactile electrodes according to the manu-
facturer's instructions (InBody 520; Biospace, Seoul,
Korea). Participants stood upright on the foot electrodes
with their arms held vertically while loosely gripping the
hand electrodes. In this manner, the eight tactile elec-
trodes were placed in contact with the thumb and palm of
each hand and the front and rear soles of each foot. The
microprocessor-controlled switches and the impedance
analyzer were used to measure the segmental resistances
of the arms, trunk, and legs without accounting for fluid
redistribution. Alternating currents with a magnitude of
100 μA and frequencies of 5 to 500 kHz were used.
The bone mineral density (BMD; g/cm2) of the lumbar
spine (L2-L4) was measured by dual-energy X-ray absorp-
tiometry (DEXA) using DPX-MD+ (General Electric, Mad-
ison, Wis, United States). All scans performed on the same
machine by the same operator were analyzed with the
same software. The results were reported as a T score, a
standard deviation measure related to peak bone mass for
a young adult.
Laboratory procedures
Baseline blood samples were taken after an overnight fast.
Blood samples were collected and delivered to the Seoul
Clinical Laboratories (Seoul, Korea) for blood assays. Lab-
oratory tests included complete blood count, thyroid
function test, liver function test, BUN/Cr, VDRL, vitamin
B12, folate, blood sugar, lipid profile, homocysteine, C-
reactive protein, and genotyping of the APOE polymor-
phism. These laboratory analyses were determined using
commercially available kits. We classified the APOE ε4
polymorphism as present (homozygous or heterozygous)
or absent. All measurements were obtained in a blind
manner to each other and to the diagnosis.
Carotid intima-media thickness (IMT)
Extracranial IMT measurements were performed accord-
ing to a predetermined, standardized scanning protocol
using high-resolution B-mode ultrasonography with a
7.5-MHz linear-type probe (GM-2600A, Panavista, Matsu-
shita Co., Japan), as described previously [46]. Briefly, an
experienced technologist who was blinded to the partici-
pant's clinical data made all ultrasound measurements.
The IMT was evaluated as the distance between the lumi-
nal-intimal interface and the medial-adventitial interface,
and it was measured with the use of an electronic caliper
on the frozen frame of a suitable longitudinal image. Six
to eight measurements of far-wall IMT were taken manu-
ally using ultrasound calipers, and the average values of
these readings were used in the analyses. The mean and
maximum of left and right IMTs were used in the analyses.
Arterial Stiffness
Arterial stiffness was assessed by brachial-ankle PWV
(baPWV) on both sides using an automated system
(VP2000, Colin Medical Technology, Japan), using previ-
ously published methods [47]. In brief, blood pressure
was checked in a sitting position after 10 min of restPage 4 of 7
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eral brachial and ankle blood pressures, and carotid and
femoral arterial pulse waves were measured simultane-
ously. Ten-second-interval bilateral brachial and posterior
tibial arterial pressure waveforms were recorded using
extremity cuffs connected to a plethysmographic sensor
and an oscillometric pressure sensor wrapped around
both arms and ankles. PWV was calculated from the dis-
tance between the two arterial recording sites divided by
transit time. The time delay between the right brachial and
posterior tibial arteries was obtained. The path lengths
from brachial arteries to the ankle and the baPWV were
calculated automatically. The validity and reliability of the
automated device for measuring baPWV have been estab-
lished previously [47].
Ankle-brachial index (ABI) was used as a measure of
occlusive disease to the lower extremities. Pressures were
measured in the right arm and both ankles (posterior tib-
ial artery) automatically. Systolic blood pressure (SBP) in
the ankle was divided by the SBP in the arm to create an
ABI separately on each side.
Definitions
Hypertension was defined by pre-admission history, med-
ical records, and the criteria established by the Seventh
Joint National Committee on Detection, Evaluation, and
Treatment [48].
Diabetes was defined by the American Diabetes Associa-
tion (ADA) criteria using blood glucose measurements
[49]. Subjects with fasting blood glucose ≥ 126 mg/dL
(6.99 mmol/L) and or 2-h blood glucose of ≥ 200 mg/dL
(11.10 mmol/L) were classified as having diabetes. Sub-
jects were also considered to be diabetic if they reported a
history of diabetes diagnosed by a physician or if they
were on anti-hyperglycemic agents irrespective of their
blood glucose values.
Dyslipidemia was judged as present when laboratory
examination of the serum at presentation showed a high
total cholesterol level of >220 mg/dL (5.69 mmol/L), a
high triglyceride level of >150 mg/dL (1.71 mmol/L), a
low high-density-lipoprotein cholesterol level of <40 mg/
dL (1.03 mmol/L), or when a history of treatment was
present.
An ABI of ≤ 0.90 on at least one side was considered to be
evidence of occlusive disease such as peripheral arterial
disease.
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Results
The distribution of the study population is presented in
Table 1. The distribution of age and gender was not differ-
ent from that of the target population. In the screening
study, the mean age was 68.38 ± 6.06 years and 56.1%
were women. In the first-wave study, the mean age was
69.28 ± 5.44 years (67.33 ± 5.49 years when the screening
study was performed) and 57.4% were women. In the sec-
ond-wave study, the mean age was 70.95 ± 5.11 years
(66.82 ± 5.17 years when the screening study was per-
formed) and 54.8% were women. The distributional
structure of age and gender from the screening test to the
second-wave study did not differ significantly between
studies (P > 0.05).
Discussion
The AGE study was designed to obtain comprehensive
epidemiological data on the health status and common
geriatric diseases of elderly Koreans and to establish a
comprehensive information database on public health
and functional status in elderly Koreans. Strengths of the
study are that the participants were randomly selected
from a defined population in Korea. This study was well
designed with stratified randomized sampling methods,
representing a geographically-defined Korean population.
All participants were assessed using structured instru-
Table 1: Demographic characteristics of subjects
Target population in Ansan-city Baseline subjects
Total Men Women Total Men Women
36735 14677 22058 2767 1213 1554
Age (years)
60–64 12814 (34.9) 5771 (39.2) 7043 (31.9) 912 (33.0) 425 (35.0) 487 (31.3)
65–69 10386 (28.3) 4175 (28.5) 6211 (28.2) 774 (28.0) 327 (27.0) 447 (28.8)
70–74 6837 (18.6) 2494 (17.0) 4342 (19.7) 553 (20.0) 249 (20.5) 304 (19.6)
75–79 4353 (11.8) 1436 (9.8) 2917 (13.2) 348 (12.6) 144 (11.9) 204 (13.1)
80–84 2346 (6.4) 801 (5.5) 1545 (7.0) 180 (6.5) 68 (5.6) 112 (7.2)Page 5 of 7
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tests. However, this study also has some limitations. No
institutionalized elderly participants were included in this
study therefore this sample population might not be com-
pletely representative of the geriatric Korean population.
Furthermore, the study's cohort was not large enough to
estimate the prevalence of low-level geriatric diseases.
Additional recruitment will be performed at each follow-
up stage to increase sub-populations in areas of interest or
to refresh the AGE cohort as it ages.
Longitudinal follow-up is ongoing and the comprehen-
sive health data obtained is expected to contribute to pol-
icy formulation and planning of health, welfare
management, and other social services for elderly persons
in Korea.
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